Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Treatment Response of Peritoneal Metastases in Ovarian Cancer Using Diffusion Weighted Magnetic Resonance Imaging.

NCT01505829 is registered in ClinicalTrials.gov with Institute of Cancer Research, United Kingdom as lead sponsor.

NCT NCT01505829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01505829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Treatment Response of Peritoneal Metastases in Ovarian Cancer Using Diffusion Weighted Magnetic Resonance Imaging.
Lead sponsor
Institute of Cancer Research, United Kingdom
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
October 13, 2018
Enrollment
134 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer, peritoneal metastases